⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ORKA News
Oruka Therapeutics, Inc. Common Stock
Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026
globenewswire.com
ORKA
Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026
globenewswire.com
ORKA
Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
ORKA
Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
ORKA
Oruka Therapeutics to Participate in Multiple Upcoming Conferences
globenewswire.com
ORKA
Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001
globenewswire.com
ORKA
Oruka Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
ORKA
Oruka Therapeutics Announces New Board Member and Board Transition
globenewswire.com
ORKA
Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
ORKA
Oruka Therapeutics to Present at Multiple November Investor Conferences
globenewswire.com
ORKA